ConductScience.org, home

Paper36713397

The impact of cross-reactive immunity on the emergence of SARS-CoV-2 variants.

Thompson RN and 6 others. Front Immunol, 2022. Cited by 13 papers, by iCite.

Cite this record

ConductScience Library. The impact of cross-reactive immunity on the emergence of SARS-CoV-2 variants. Papers, record 36713397. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36713397

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The impact of cross-reactive immunity on the emergence of SARS-CoV-2 variants.
PubMed
Journal
Front Immunol
PubMed
Year
2022
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
13
iCite
Relative citation ratio, by iCite
0.98
iCite
Revised in PubMed
2024-09-11
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Thompson RNRobin N
2Southall EEmma
3Daon YYair
4Lovell-Read FAFrancesca A
5Iwami SShingo
6Thompson CPCraig P
7Obolski UUri

Source PubMed

Download CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
SARS-CoV-2Major topic
COVID-19Major topic
Humans
Pandemics
Cross Reactions

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
BB/M011224/1Biotechnology and Biological Sciences Research CouncilUnited KingdomPubMed

Source PubMed

Download CSV of grants

References58

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
131056047Increased frequency of travel in the presence of cross-immunity may act to decrease the chance of a global pandemic.Philos Trans R Soc Lond B Biol Sci2019https://conductscience.org/library/papers/31056047PubMed
232502274Estimating COVID-19 outbreak risk through air travel.J Travel Med2020https://conductscience.org/library/papers/32502274PubMed
335090165Three exposures to the spike protein of SARS-CoV-2 by either infection or vaccination elicit superior neutralizing immunity to all variants of concern.Nat Med2022https://conductscience.org/library/papers/35090165PubMed
435608920Fatal COVID-19 outcomes are associated with an antibody response targeting epitopes shared with endemic coronaviruses.JCI Insight2022https://conductscience.org/library/papers/35608920PubMed
534301854Spatiotemporal invasion dynamics of SARS-CoV-2 lineage B.1.1.7 emergence.Science2021https://conductscience.org/library/papers/34301854PubMed
635536864Superinfection exclusion: A viral strategy with short-term benefits and long-term drawbacks.PLoS Comput Biol2022https://conductscience.org/library/papers/35536864PubMed
735355988Heterologous Immune Responses of Serum IgG and Secretory IgA Against the Spike Protein of Endemic Coronaviruses During Severe COVID-19.Front Immunol2022https://conductscience.org/library/papers/35355988PubMed
836182669SARS-CoV-2 in immunocompromised individuals.Immunity2022https://conductscience.org/library/papers/36182669PubMed
932272134Modeling the waning and boosting of immunity from infection or vaccination.J Theor Biol2020https://conductscience.org/library/papers/32272134PubMed
1035613036Protection and Waning of Natural and Hybrid Immunity to SARS-CoV-2.N Engl J Med2022https://conductscience.org/library/papers/35613036PubMed
1133430856Potential impact of individual exposure histories to endemic human coronaviruses on age-dependent severity of COVID-19.BMC Med2021https://conductscience.org/library/papers/33430856PubMed
1234758478Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2.Nature2022https://conductscience.org/library/papers/34758478PubMed
1334773173The impact of infection-derived immunity on disease dynamics.J Math Biol2021https://conductscience.org/library/papers/34773173PubMed
1435617962IgG targeting distinct seasonal coronavirus- conserved SARS-CoV-2 spike subdomains correlates with differential COVID-19 disease outcomes.Cell Rep2022https://conductscience.org/library/papers/35617962PubMed
1532576668A mathematical model reveals the influence of population heterogeneity on herd immunity to SARS-CoV-2.Science2020https://conductscience.org/library/papers/32576668PubMed
1635716723A direct comparison of methods for assessing the threat from emerging infectious diseases in seasonally varying environments.J Theor Biol2022https://conductscience.org/library/papers/35716723PubMed
1733171074Will an outbreak exceed available resources for control? Estimating the risk from invading pathogens using practical definitions of a severe epidemic.J R Soc Interface2020https://conductscience.org/library/papers/33171074PubMed
1835139269Protection against the Omicron Variant from Previous SARS-CoV-2 Infection.N Engl J Med2022https://conductscience.org/library/papers/35139269PubMed
1934652962Early cross-coronavirus reactive signatures of humoral immunity against COVID-19.Sci Immunol2021https://conductscience.org/library/papers/34652962PubMed
2016013892Appropriate models for the management of infectious diseases.PLoS Med2005https://conductscience.org/library/papers/16013892PubMed

See all 58 referencesDownload CSV of references

Cited by12

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.

PMIDTitleJournalYearIn PapersSource
42821564Demographic changes and behavioural responses shape vulnerability to infectious disease outbreaks.PLoS Comput Biol2026https://conductscience.org/library/papers/42821564PubMed
42325475Modeling two-strain competition with reinfection: Mathematical analyses and epidemiological implications.Infect Dis Model2026https://conductscience.org/library/papers/42325475PubMed
41012101Role of the Virome in Vaccine-Induced Immunization.Vaccines (Basel)2025https://conductscience.org/library/papers/41012101PubMed
40696544The Mathematics of Serocatalytic Models With Applications to Public Health Data.Stat Med2025https://conductscience.org/library/papers/40696544PubMed
40062847Pathogen priming alters host transmission potential and predictors of transmissibility in a wild songbird species.mSphere2025https://conductscience.org/library/papers/40062847PubMed
39556748How cultural innovations trigger the emergence of new pathogens.Proc Natl Acad Sci U S A2024https://conductscience.org/library/papers/39556748PubMed
39116038Prioritising older individuals for COVID-19 booster vaccination leads to optimal public health outcomes in a range of socio-economic settings.PLoS Comput Biol2024https://conductscience.org/library/papers/39116038PubMed
37932355Immune imprinting and next-generation coronavirus vaccines.Nat Microbiol2023https://conductscience.org/library/papers/37932355PubMed
37788317Analysis of the risk and pre-emptive control of viral outbreaks accounting for within-host dynamics: SARS-CoV-2 as a case study.Proc Natl Acad Sci U S A2023https://conductscience.org/library/papers/37788317PubMed
37640233Modeling the XBB strain of SARS-CoV-2: Competition between variants and impact of reinfection.J Theor Biol2023https://conductscience.org/library/papers/37640233PubMed
37290500An adaptive testing strategy for efficient utilization of healthcare resources during an epidemic.J Theor Biol2023https://conductscience.org/library/papers/37290500PubMed
36992136Impact of MERS-CoV and SARS-CoV-2 Viral Infection on Immunoglobulin-IgG Cross-Reactivity.Vaccines (Basel)2023https://conductscience.org/library/papers/36992136PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36713397

GET https://conductscience.org/api/papers/v1/36713397/references?page=2